JP2017534667A5 - - Google Patents

Download PDF

Info

Publication number
JP2017534667A5
JP2017534667A5 JP2017527358A JP2017527358A JP2017534667A5 JP 2017534667 A5 JP2017534667 A5 JP 2017534667A5 JP 2017527358 A JP2017527358 A JP 2017527358A JP 2017527358 A JP2017527358 A JP 2017527358A JP 2017534667 A5 JP2017534667 A5 JP 2017534667A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
tablet
composition according
weight
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017527358A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017534667A (ja
JP6901393B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/061448 external-priority patent/WO2016081671A1/en
Publication of JP2017534667A publication Critical patent/JP2017534667A/ja
Publication of JP2017534667A5 publication Critical patent/JP2017534667A5/ja
Priority to JP2021100203A priority Critical patent/JP2021152046A/ja
Application granted granted Critical
Publication of JP6901393B2 publication Critical patent/JP6901393B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017527358A 2014-11-19 2015-11-19 フマル酸ジメチルを含む医薬マトリクス製剤 Expired - Fee Related JP6901393B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021100203A JP2021152046A (ja) 2014-11-19 2021-06-16 フマル酸ジメチルを含む医薬マトリクス製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462081907P 2014-11-19 2014-11-19
US62/081,907 2014-11-19
PCT/US2015/061448 WO2016081671A1 (en) 2014-11-19 2015-11-19 Pharmaceutical matrix formulations comprising dimethyl fumarate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021100203A Division JP2021152046A (ja) 2014-11-19 2021-06-16 フマル酸ジメチルを含む医薬マトリクス製剤

Publications (3)

Publication Number Publication Date
JP2017534667A JP2017534667A (ja) 2017-11-24
JP2017534667A5 true JP2017534667A5 (https=) 2018-12-27
JP6901393B2 JP6901393B2 (ja) 2021-07-14

Family

ID=54838418

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017527358A Expired - Fee Related JP6901393B2 (ja) 2014-11-19 2015-11-19 フマル酸ジメチルを含む医薬マトリクス製剤
JP2021100203A Pending JP2021152046A (ja) 2014-11-19 2021-06-16 フマル酸ジメチルを含む医薬マトリクス製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021100203A Pending JP2021152046A (ja) 2014-11-19 2021-06-16 フマル酸ジメチルを含む医薬マトリクス製剤

Country Status (13)

Country Link
US (2) US20190083404A1 (https=)
EP (1) EP3220897A1 (https=)
JP (2) JP6901393B2 (https=)
KR (1) KR20170086053A (https=)
CN (2) CN113262205A (https=)
AU (2) AU2015349891B2 (https=)
CA (1) CA2967645A1 (https=)
EA (1) EA201791089A1 (https=)
HK (1) HK1244215A1 (https=)
IL (1) IL252105A0 (https=)
MA (1) MA40990A (https=)
MX (1) MX391400B (https=)
WO (1) WO2016081671A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2987895A1 (en) 2015-06-01 2016-12-08 Sun Pharmaceutical Industries Ltd. Pharmaceutical compositions of dimethyl fumarate
KR102714380B1 (ko) 2021-06-09 2024-10-11 강원대학교산학협력단 경구 투여용 나노입자 및 이의 제조방법
WO2023036702A1 (en) 2021-09-09 2023-03-16 It Pharmagus Limited Method for the manufacturing of a solid body as an oral dosage form of a pharmaceutical or a food supplement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781058B2 (en) * 1999-08-31 2005-05-05 Grunenthal Gmbh Delayed-action form of administration containing tramadol saccharinate
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
WO2010079222A1 (en) * 2009-01-09 2010-07-15 Forward Pharma A/S Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
US20120165404A1 (en) * 2009-04-29 2012-06-28 Biogen Idec Ma Inc. Treatment of neurodegeneration and neuroinflammation
EP2678305A4 (en) * 2011-02-25 2015-11-04 Univ Johns Hopkins CHALCONE DERIVATIVES AS NRF2 ACTIVATORS
US20130158077A1 (en) * 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions
NZ627980A (en) * 2012-02-07 2016-12-23 Biogen Ma Inc Pharmaceutical compositions containing dimethyl fumarate
AU2013305684B2 (en) * 2012-08-22 2016-11-24 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
AR094277A1 (es) * 2012-12-21 2015-07-22 Biogen Idec Inc Derivados de fumarato sustituidos con deuterio
CN105369562B (zh) * 2014-08-28 2019-12-20 青岛海尔洗衣机有限公司 一种带有防衣物褪色提醒功能的洗衣机

Similar Documents

Publication Publication Date Title
AU2015349896B2 (en) Pharmaceutical bead formulations comprising dimethyl fumarate
US20210220281A1 (en) Oral pharmaceutical compositions of mesalazine
CN1178659C (zh) 控释活性化合物的药物制剂
JP2017534668A5 (https=)
JP2021152050A (ja) フマル酸ジメチルを含む医薬ビーズ製剤
JP2021152046A (ja) フマル酸ジメチルを含む医薬マトリクス製剤
JP2017534667A5 (https=)
JP2019504859A5 (https=)
US20140010883A1 (en) Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
US9561241B1 (en) Gastroretentive dosage forms for minocycline
HK1077203A (en) Medicament formulation with a controlled release of an active compound
HK1103021A (en) Medicament formulation with a controlled release of an active agent